Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture

PURPOSE: Combined treatment with alendronate and alfacalcidol is more useful to increase bone mineral density (BMD) than alendronate or alfacalcidol alone. A retrospective study was conducted to investigate the 3-year outcome of combined treatment with alendronate and alfacalcidol in patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Jun, Sato, Yoshihiro, Uzawa, Mitsuyoshi, Takeda, Tsuyoshi, Matsumoto, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132096/
https://www.ncbi.nlm.nih.gov/pubmed/21753888
http://dx.doi.org/10.2147/TCRM.S22167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132096/
https://www.ncbi.nlm.nih.gov/pubmed/21753888
http://dx.doi.org/10.2147/TCRM.S22167

Ejemplares similares